Motexafin gadolinium: a novel radiosensitizer for brain tumors Other Scholarly Work

Francis, Dave, Richards, Gregory M, Forouzannia, Afshin et al. (2009). Motexafin gadolinium: a novel radiosensitizer for brain tumors . EXPERT OPINION ON PHARMACOTHERAPY, 10(13), 2171-2180. 10.1517/14656560903179325

cited authors

  • Francis, Dave; Richards, Gregory M; Forouzannia, Afshin; Mehta, Minesh P; Khuntia, Deepak

sustainable development goals

authors

publication date

  • September 1, 2009

webpage

published in

keywords

  • BREAST-CANCER
  • CANCER PATIENTS
  • Life Sciences & Biomedicine
  • PHASE-III
  • Pharmacology & Pharmacy
  • RADIATION-THERAPY
  • RADIOTHERAPY
  • RANDOMIZED-TRIAL
  • REDUCTASE
  • SINGLE METASTASES
  • SURVIVAL
  • Science & Technology
  • TEMOZOLOMIDE
  • brain metastasis
  • glioblastoma
  • motexafin gadolinium
  • radiation sensitizer

Digital Object Identifier (DOI)

publisher

  • TAYLOR & FRANCIS LTD

start page

  • 2171

end page

  • 2180

volume

  • 10

issue

  • 13